 Reata Pharmaceuticals, Inc. NASDAQ:RETA Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Warren Huff - Chief Executive Officer Colin Meyer - Chief Innovation Officer Dawn Bir - Chief Commercial Officer Manmeet Soni - President Conference Call Participants Yigal Nochomovitz - Citigroup Madhu Kumar - Goldman Sachs Charles Duncan - Cantor Fitzgerald Annabel Samimy - Stifel Maury Raycroft - Jefferies Operator Thank you for standing by and welcome to Reata Pharmaceuticals Second Quarter 2022 Financial Results and Update on Development Programs Conference Call. An audio recording of todays webcast will be available shortly after the call in the Investors section of Reatas website at reatapharma.com. 